The OEM Collaboration: Navigating Quality & Regulation in Med Device Advanced Manufacturing

The integration of advanced manufacturing technologies into medical product development presents both opportunities and challenges. While original equipment manufacturers (OEMs) specializing in additive manufacturing and other advanced technologies bring critical technical expertise, they often lack familiarity with the regulatory and quality management framework required for medical devices, biologics, and pharmaceuticals. This knowledge gap can impede product development timelines and complicate regulatory submissions.

Effective collaboration between medical device manufacturers and advanced manufacturing OEMs is essential to ensure innovative products meet regulatory requirements and can be efficiently reviewed for the U.S. healthcare market. These partnerships often involve complementary but distinct areas of expertise. For instance, while a medical device manufacturer is responsible for maintaining device-specific documentation and ensuring compliance with FDA quality system regulations, the additive manufacturing OEM may contribute specialized knowledge in design for additive manufacturing principles—such as optimizing part geometry for build efficiency or material performance. Bridging these knowledge domains is critical to aligning technical innovation with regulatory expectations and ensuring a smooth path to FDA review.

Using an example from Veterans Health Administration's X_Labs, this session will highlight common challenges faced by advanced manufacturing OEMs as they navigate FDA expectations, including areas of confusion related to quality system regulations, documentation standards, and risk management. By fostering mutual understanding and alignment between medical device manufacturers and OEMs, stakeholders can better leverage advanced manufacturing to accelerate innovation while maintaining regulatory compliance and product quality.